Morningstar Stock Screener Review: Research Depth, Ratings, and Portfolio Fit
By Darlene Aberin Updated
The Morningstar stock screener included in its Investor subscription is most useful for investors who do not want screening to stop at a list of tickers. The platform combines quantitative filters with Morningstar ratings, analyst research, fair-value estimates, watchlists, and portfolio analysis.
Morningstar Investor costs $249 per year or $34.95 per month, according to Morningstar's own pricing on October 15, 2026. The annual plan works out to $20.75 per month. Its value depends heavily on whether an investor uses the research and portfolio layers beyond the first set of filters, so the Morningstar stock screener is best judged as part of that whole package.
Key Takeaways
- Morningstar Investor's screener searches thousands of securities and indexes, including global investments, across stocks, ETFs, and mutual funds.
- Morningstar says users can build screens from more than 200 unique data points or start from pre-filtered investment lists.
- The screener connects with Morningstar ratings for fair value and competitive advantage, watchlists, and portfolio tools.
- Morningstar Investor costs $249 per year or $34.95 per month, with a seven-day free trial for new users.
- Portfolio X-Ray shows asset allocation, sector weightings, and fees, and Stock Intersection shows concentrated positions.
- The platform suits long-term investors more than short-term technical traders.
What the Morningstar Stock Screener Can Filter
According to Morningstar's screener page, the Investor screener searches thousands of securities and indexes, including global investments, filtered by the data points each user chooses. The same page covers stocks, ETFs, and mutual funds, and lets users compare up to five securities side by side.
Morningstar's overview page says users can start from pre-filtered investment lists or create their own screen using more than 200 unique data points. That gives newer users a starting framework and lets experienced investors build exactly the screen they want.
The range of security types is useful because each one needs a different framework. A fund screen may focus on fees, risk, category, and performance, while a stock screen may focus on valuation, profitability, financial health, and analyst ratings. The Morningstar stock screener handles both within one subscription.
Morningstar Ratings Add a Research Layer to Screening
The main reason Morningstar differs from a basic screener is that its own research can become part of the filter. Morningstar describes its ratings as a yardstick for measuring a security's strength, from fair value and competitive advantage for stocks to a fund's ability to outperform its peers over time.
Why Ratings Change a Screen
A low valuation multiple can look attractive until the business turns out to have weak economics or a fading competitive position. A rating for competitive advantage adds a check that a pure numbers screen cannot provide, so the list that comes back reflects business quality as well as price.
Why Ratings Still Need Checking
A strong company can be a poor investment if its price already reflects optimistic assumptions. A fair-value estimate helps here, but it rests on the analyst's own forecasts. Investors should read the reasoning behind a rating rather than treating the label itself as the conclusion.
Pre-Filtered Lists Reduce the Work of Building Criteria
Morningstar offers pre-filtered investment lists that reflect common investment approaches. These help investors who are still learning which criteria to combine.
Using Lists as a Starting Point
A pre-filtered list is a ready-made set of assumptions about what makes an investment attractive. Running one shows how criteria interact, and the results can be adjusted by adding or removing filters. That makes a list a practical way to learn screening, rather than a final answer.
Knowing Why a Stock Qualifies
Investors should still understand why each company passed. A stock can meet a list's conditions for reasons the investor would not accept, such as a temporary jump in earnings. Opening the company page and checking the numbers behind the match keeps the screen honest.
Custom Screens Become More Useful Over Time
Morningstar's help center describes tools for editing data and columns in the screener, adding, removing, and arranging data points, and sending screened securities to watchlists.
This becomes more valuable as a research process matures. Investors often find that only a handful of metrics consistently influence their decisions. A custom screen built around those metrics, with the matching columns on display, turns the Morningstar stock screener into a repeatable weekly routine.
Portfolio Tools Are a Major Part of the Value
Morningstar's research platform extends beyond screening. According to its portfolio tools page, Portfolio X-Ray lays out a portfolio's overall asset allocation, sector weightings, fees, and more. Stock Intersection identifies concentrated positions, showing how much any single security can affect the portfolio.
The Question After the Screen
These tools add a second question once a stock passes a screen: what would owning it do to the portfolio? A company can look attractive alone while adding to a sector the investor already holds heavily through funds. Stock Intersection makes that overlap visible before a new position is added.
Why Fund Holders Benefit Most
Many investors hold individual stocks alongside mutual funds or ETFs. Those funds often own the same large companies. Without a tool like Stock Intersection, an investor can end up far more concentrated in a few names than the list of holdings suggests.
Morningstar Investor Pricing in 2026
Morningstar lists two billing options for Investor. New users can start with a seven-day free trial, and Morningstar states that the subscription rate can change without notice.
| Plan | Price |
|---|---|
| Annual | $249 per year |
| Monthly | $34.95 per month |
| Annual, monthly equivalent | $20.75 per month |
Source: Morningstar Investor pricing, checked October 15, 2026.
Morningstar says the annual plan saves 41% compared with paying monthly for a year. Promotional prices may apply to the first year of an annual plan.
Where Morningstar Is Strongest
The platform's strengths line up with a long-term, research-led approach to investing.
Long-Term Stock Research
The combination of company data, analyst research, fair-value estimates, and competitive-position ratings supports a long-horizon fundamental process. An investor can screen for candidates, read the analyst view, and compare the estimate of value with the current price in one place.
Fund and ETF Research
Morningstar has deep roots in fund analysis. That makes the platform useful for investors who screen both individual companies and funds, since the same subscription covers fund ratings, fees, and performance alongside stock research and screening. That breadth is a key reason fund holders choose Morningstar over stock-only screeners.
Portfolio Construction
The link between screening and portfolio analysis makes it easier to judge whether a new idea improves or duplicates the existing portfolio. X-Ray and Stock Intersection show the effect of a holding on allocation and concentration before a decision is made.
Where Morningstar Is Less Compelling
Morningstar is not primarily a technical trading platform. Investors who need intraday alerts, complex chart layouts, momentum filters, or specialized technical scans may find TradingView or Finviz more efficient.
The subscription cost can also be hard to justify for investors who only want basic screening. Several free screeners cover simple valuation and growth filters, so the case for paying rests on using the research and portfolio features regularly.
Morningstar Compared With a Basic Screener
The comparison below shows where the extra layers make a difference and where a simpler tool can match it.
| Research Task | Morningstar Investor | Basic Screening Platform |
|---|---|---|
| Quantitative stock filters | Strong | Strong |
| Analyst-written research | Strong | Usually limited |
| Fair-value estimates | Strong | Usually limited |
| Portfolio overlap analysis | Strong | Often absent |
| Technical charting | Moderate | Can be stronger elsewhere |
| Fund research | Very strong | Varies |
Morningstar's advantage is not that it screens faster. It is that the screen connects to a broader research framework.
How to Use Morningstar Screening Without Overrelying on Ratings
A rating can save time, but it should not replace analysis. An investor can use Morningstar's fair-value or competitive-advantage measures to narrow a list, then review the business model, financial statements, current price, risks, and the assumptions behind each rating.
Pairing those results with stock risk metrics can also help separate companies that look attractive on valuation from stocks with unusually high volatility or drawdown risk. A well-built Morningstar stock screener search is one step in that process, not the whole of it. The rest is stock analysis fundamentals: reading the statements behind each result.
A Sample Long-Term Screening Workflow
The Morningstar stock screener works best as the first step in a longer process. The workflow below shows how its features fit together for a long-term investor.
Step One: Screen for Quality and Value
Start with a screen that combines a competitive-advantage rating, a valuation measure such as price to fair value, and a basic financial health filter. That produces a short list of companies that look sound and not obviously overpriced, which is a manageable place to begin research.
Step Two: Read the Analyst Research
Open the analyst report for each company on the list. The aim is to understand the reasoning behind the rating and the fair-value estimate, including which assumptions about growth and margins it depends on, rather than simply accepting the label.
Step Three: Check Portfolio Fit
Add the remaining candidates to a watchlist and use Portfolio X-Ray and Stock Intersection to see how each would change sector weightings and concentration. A stock that duplicates exposure already held through funds may add less than it first appears.
Questions to Answer During the Free Trial
The seven-day free trial is short, so it helps to arrive with a plan. These questions show quickly whether the subscription fits.
Do You Use the Ratings?
Run a screen with and without Morningstar's ratings. If the ratings change which companies make the list in ways you find useful, the research layer is earning its place. If you ignore them, a free screener may serve you just as well.
Do You Hold Funds Alongside Stocks?
Run Portfolio X-Ray on your current holdings. Investors who own both funds and individual stocks often find overlaps they did not expect, and that analysis is one of the features hardest to replace with free tools. Running it during the trial shows whether that insight is useful to you.
Comparing and Tracking Screen Results
Finding companies is only part of the job. The Morningstar stock screener connects with tools for comparing and tracking them afterward.
Side-by-Side Comparison
Morningstar's screener page says Investor can show up to five securities side by side. Comparing candidates on the same metrics at once makes differences in valuation, profitability, and financial health easier to see than switching between separate company pages. It also helps narrow a short list to one or two names.
Watchlists for Follow-Up
Screened securities can be sent straight to watchlists, according to Morningstar's help center. A watchlist turns a one-off screen into an ongoing list, so price changes and new research on each candidate can be tracked over the following weeks. That keeps promising ideas from being forgotten.
Alternatives Worth Comparing
Morningstar is one of several options, and the right choice depends on how much of its research layer an investor will use.
Free Screeners
Finviz, Yahoo Finance, TradingView, Koyfin, and Stock Analysis all offer free screening. For basic filtering by valuation or growth, a free tool may be enough, and it costs nothing to test one alongside the Morningstar trial. Running the same filters in both shows whether Morningstar's extra research changes the results.
Other Paid Research Platforms
Koyfin's Plus plan costs $39 per month on annual billing and focuses on financial history, estimates, and dashboards rather than analyst ratings. Investors who want long histories more than analyst opinions may find that focus fits their process better, and its free plan allows a direct comparison. The Zacks stock screener takes a different route, ranking stocks by earnings-estimate revisions.
What Fair Value and Competitive Advantage Mean
Two of the ratings most often used in a Morningstar screen describe different things, and it helps to keep them apart.
Fair Value
A fair-value estimate is an analyst's view of what a share is worth, based on forecasts of the company's future cash flows. Comparing it with the market price shows whether the stock looks cheap or expensive under that analyst's assumptions, which can differ from another analyst's.
Competitive Advantage
A competitive-advantage rating judges how well a company can protect its profits from rivals over time. It says nothing about price, so a company with a strong advantage can still trade above its estimated fair value, and the two ratings work best together.
Is the Annual Plan Worth It?
Twelve monthly payments of $34.95 come to $419.40 a year, compared with $249 for the annual plan. That difference of $170.40 is the saving Morningstar describes as 41%. The annual plan makes sense for investors who expect to use the tools all year, while the monthly plan suits those who want a longer test after the free trial before committing.
Who Gets the Most Value From Morningstar Investor?
Morningstar Investor is most attractive for investors who hold stocks and funds together, want independent analyst research, care about fair value and competitive advantage, and review portfolio allocation regularly.
Investors focused mainly on short-term technical trading are less likely to use its strongest features. For them, the Morningstar stock screener covers more research than they need, while charting and alerts are deeper elsewhere.
Morningstar Is More Than a Screener, Which Is Also Its Main Tradeoff
The Morningstar stock screener is valuable because it sits inside a larger research and portfolio system. That can make the $249 annual subscription worthwhile for investors who use ratings, analyst research, Portfolio X-Ray, watchlists, and screening together.
For someone who only needs to filter U.S. stocks by valuation or growth, a free screener may do the job more efficiently, and without any subscription cost. The seven-day trial is a sensible way to test which group an investor falls into before paying. A practical test is to run the same screen in Morningstar and in a free tool, then compare not only the lists but also how much further research each one supports. If the ratings, analyst notes, and portfolio checks change the decision, the subscription is doing work that a free screener cannot. If the lists and the next steps look the same, the free tool is likely enough for now.
Frequently Asked Questions
Does Morningstar Have a Stock Screener?
Yes. Morningstar Investor includes a screener for stocks, ETFs, and mutual funds, with custom screens built from more than 200 data points and pre-filtered investment lists for common approaches.
How Much Does Morningstar Investor Cost?
Morningstar Investor costs $249 per year or $34.95 per month. The annual option works out to $20.75 monthly, and new users can start with a seven-day free trial.
Is Morningstar Good for Stock Research?
Yes, especially for long-term investors. Its strength comes from combining screening with analyst research, fair-value estimates, competitive-advantage ratings, watchlists, and portfolio analysis in one subscription.
Is Morningstar Better Than Finviz?
They suit different needs. Morningstar is stronger for analyst research, fund analysis, and portfolio context, while Finviz is faster for U.S. stock screening, technical filters, and market maps.
Can Morningstar Ratings Replace My Own Research?
No. Ratings can narrow a list and add context, but investors should still examine financial statements, valuation assumptions, business risks, and portfolio fit before reaching their own view.